The epigenetic progenitor origin of human cancer

Andrew P Feinberg, Rolf Ohlsson, Steven Henikoff

Research output: Contribution to journalArticle

Abstract

Cancer is widely perceived as a heterogeneous group of disorders with markedly different biological properties, which are caused by a series of clonally selected genetic changes in key tumour-suppressor genes and oncogenes. However, recent data suggest that cancer has a fundamentally common basis that is grounded in a polyclonal epigenetic disruption of stem/progenitor cells, mediated by 'tumour-progenitor genes'. Furthermore, tumour cell heterogeneity is due in part to epigenetic variation in progenitor cells, and epigenetic plasticity together with genetic lesions drives tumour progression. This crucial early role for epigenetic alterations in cancer is in addition to epigenetic alterations that can substitute for genetic variation later in tumour progression. Therefore, non-neoplastic but epigenetically disrupted stem/progenitor cells might be a crucial target for cancer risk assessment and chemoprevention.

Original languageEnglish (US)
Pages (from-to)21-33
Number of pages13
JournalNature Reviews Genetics
Volume7
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Epigenomics
epigenetics
stem cells
neoplasms
Stem Cells
Neoplasms
chemoprevention
tumor suppressor genes
oncogenes
Chemoprevention
lesions (animal)
risk assessment
Tumor Suppressor Genes
Oncogenes
genetic variation
Genes
genes

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Genetics
  • Genetics(clinical)

Cite this

The epigenetic progenitor origin of human cancer. / Feinberg, Andrew P; Ohlsson, Rolf; Henikoff, Steven.

In: Nature Reviews Genetics, Vol. 7, No. 1, 01.2006, p. 21-33.

Research output: Contribution to journalArticle

Feinberg, Andrew P ; Ohlsson, Rolf ; Henikoff, Steven. / The epigenetic progenitor origin of human cancer. In: Nature Reviews Genetics. 2006 ; Vol. 7, No. 1. pp. 21-33.
@article{7cd47797a2064c46b56430412f4f6e72,
title = "The epigenetic progenitor origin of human cancer",
abstract = "Cancer is widely perceived as a heterogeneous group of disorders with markedly different biological properties, which are caused by a series of clonally selected genetic changes in key tumour-suppressor genes and oncogenes. However, recent data suggest that cancer has a fundamentally common basis that is grounded in a polyclonal epigenetic disruption of stem/progenitor cells, mediated by 'tumour-progenitor genes'. Furthermore, tumour cell heterogeneity is due in part to epigenetic variation in progenitor cells, and epigenetic plasticity together with genetic lesions drives tumour progression. This crucial early role for epigenetic alterations in cancer is in addition to epigenetic alterations that can substitute for genetic variation later in tumour progression. Therefore, non-neoplastic but epigenetically disrupted stem/progenitor cells might be a crucial target for cancer risk assessment and chemoprevention.",
author = "Feinberg, {Andrew P} and Rolf Ohlsson and Steven Henikoff",
year = "2006",
month = "1",
doi = "10.1038/nrg1748",
language = "English (US)",
volume = "7",
pages = "21--33",
journal = "Nature Reviews Genetics",
issn = "1471-0056",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The epigenetic progenitor origin of human cancer

AU - Feinberg, Andrew P

AU - Ohlsson, Rolf

AU - Henikoff, Steven

PY - 2006/1

Y1 - 2006/1

N2 - Cancer is widely perceived as a heterogeneous group of disorders with markedly different biological properties, which are caused by a series of clonally selected genetic changes in key tumour-suppressor genes and oncogenes. However, recent data suggest that cancer has a fundamentally common basis that is grounded in a polyclonal epigenetic disruption of stem/progenitor cells, mediated by 'tumour-progenitor genes'. Furthermore, tumour cell heterogeneity is due in part to epigenetic variation in progenitor cells, and epigenetic plasticity together with genetic lesions drives tumour progression. This crucial early role for epigenetic alterations in cancer is in addition to epigenetic alterations that can substitute for genetic variation later in tumour progression. Therefore, non-neoplastic but epigenetically disrupted stem/progenitor cells might be a crucial target for cancer risk assessment and chemoprevention.

AB - Cancer is widely perceived as a heterogeneous group of disorders with markedly different biological properties, which are caused by a series of clonally selected genetic changes in key tumour-suppressor genes and oncogenes. However, recent data suggest that cancer has a fundamentally common basis that is grounded in a polyclonal epigenetic disruption of stem/progenitor cells, mediated by 'tumour-progenitor genes'. Furthermore, tumour cell heterogeneity is due in part to epigenetic variation in progenitor cells, and epigenetic plasticity together with genetic lesions drives tumour progression. This crucial early role for epigenetic alterations in cancer is in addition to epigenetic alterations that can substitute for genetic variation later in tumour progression. Therefore, non-neoplastic but epigenetically disrupted stem/progenitor cells might be a crucial target for cancer risk assessment and chemoprevention.

UR - http://www.scopus.com/inward/record.url?scp=29244469466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244469466&partnerID=8YFLogxK

U2 - 10.1038/nrg1748

DO - 10.1038/nrg1748

M3 - Article

VL - 7

SP - 21

EP - 33

JO - Nature Reviews Genetics

JF - Nature Reviews Genetics

SN - 1471-0056

IS - 1

ER -